This is the authors' abstract. We don't add key points for this paper.
Low dose of APZ advanced the sleep rhythm and reduced nocturnal sleep time in the subjects with DSPS. Since it is not easy for physicians to treat prolonged sleep duration often associated with DSPS, this medication would become a new therapeutic option for these patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Omori et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: